Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene.

[1]  B. Bain.  Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 , 2010, Haematologica.

[2]  A. Tefferi,et al.  Chromosome 8p11.2 translocations: Prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution , 2010, American journal of hematology.

[3]  K. Sotlar,et al.  Variable presence of KITD816V in clonal haematological non‐mast cell lineage diseases associated with systemic mastocytosis (SM–AHNMD) , 2010, The Journal of pathology.

[4]  A. Tefferi,et al.  Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. , 2009, Blood.

[5]  A. Tefferi,et al.  Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. , 2009, Blood.

[6]  L. Weiss,et al.  Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma. , 2007, Leukemia research.

[7]  A. Órfão,et al.  KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. , 2006, Blood.

[8]  K. Sotlar,et al.  Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis. , 2005, Leukemia research.

[9]  K. Sotlar,et al.  Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge , 2004, Journal of Clinical Pathology.

[10]  P. Lipsky,et al.  Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. , 2002, Blood.

[11]  K. Lennert,et al.  Diagnostic criteria and classification of mastocytosis: a consensus proposal. , 2001, Leukemia research.

[12]  J. Bernhard,et al.  Mastocytosis , 1997, The Lancet.

[13]  E. Bergstralh,et al.  Significance of systemic mast cell disease with associated hematologic disorders , 1988, Cancer.

[14]  D. Cornfield,et al.  The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report. , 2008, International journal of clinical and experimental pathology.